FDA Adverse Event Malfunction Summary report: N

BD PHOENIX¿ PMIC-108

MDR report key: 19781295 · Received July 19, 2024

Report

Report Number
1119779-2024-00558
Event Type
Malfunction
Date Received
July 19, 2024
Date of Event
June 20, 2024
Report Date
August 19, 2024
Manufacturer
BECTON DICKINSON & CO. (SPARKS)
Product Code
LON
UDI-DI
30382904484188
PMA / PMN Number
SEE H.11
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AZ, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THE INFORMATION FOR THE ADDITIONAL 510K IS AS FOLLOWS: G5. PMA / 510(K)#: K020322, K021954, K022172, K023273, K023301, K024152, K030677, K031306, K031589, K031679, K032131, K033784, K033907, K040006, K040106, K040716, K050555, K051689, K053241, K060214, K060217, K060218, K060493, K070809, K082538, K082852, AND K131331. H3. A DEVICE EVALUATION IS ANTICIPATED BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Additional Manufacturer Narrative · 0

INVESTIGATION SUMMARY: THIS COMPLAINT IS FOR HIGH MIC VANCOMYCIN (VA) WITH STAPHYLOCOCCUS AUREUS WHEN USING PHOENIX PANEL PMIC-108 (CATALOG NUMBER 448418) BATCH NUMBER 3213323. THE CUSTOMER DID NOT PROVIDE PHOENIX GENERATED LAB REPORTS, ISOLATES OR PANEL RETURNS FOR THE INVESTIGATION. TO INVESTIGATE, TWO RETENTION PANELS OF THE COMPLAINT BATCH WERE INOCULATED WITH QC ISOLATE S. AUREUS A29213 AND PLACED IN A PHOENIX M50 FOR VA MIC RESULTS. IN ADDITION, ONE CONTROL PANEL FROM THE SAME MATERIAL BUT DIFFERENT BATCH WAS INOCULATED WITH QC ISOLATE S. AUREUS A29213 AND PLACED IN A PHOENIX M50 FOR VA MIC RESULT. RESULTS OF THE INVESTIGATION RETURNED ALL PANELS WITH THE EXPECTED MIC FOR VA WITH S. AUREUS. THIS COMPLAINT IS NOT CONFIRMED. THE BATCH HISTORY RECORD WAS SATISFACTORY, AND NO QUALITY NOTIFICATIONS WERE GENERATED DURING MANUFACTURING AND INSPECTION. COMPLAINT TRENDING WAS PERFORMED, AND NO TRENDS WERE IDENTIFIED ASSOCIATED WITH THIS DEFECT. BD WILL CONTINUE TO MONITOR FOR TRENDS AND TAKE ACTION AS NECESSARY. PLEASE CONTINUE TO COMMUNICATE ANY ADDITIONAL CONCERNS.

Description of Event or Problem · 0

IT WAS REPORTED WHILE USING THE BD PHOENIX¿ PMIC-108 AN UNSPECIFIED NUMBER OF PATIENT SAMPLES HAVE A HIGH MIC FOR THE DRUG VANCOMYCIN FOR THE ISOLATE STAPHYLOCOCCUS AUREUS. ONE ERRONEOUS PATIENT RESULT WAS REPORTED. THERE WAS NO PATIENT TREATMENT CHANGE AS A RESULT. CONFIRMATORY TESTING PERFORMED ON THE MICROSCAN, WHERE THE ISOLATE WAS NOT RESISTANT.

Description of Event or Problem · 0

IT WAS REPORTED WHILE USING THE BD PHOENIX¿ PMIC-108 AN UNSPECIFIED NUMBER OF PATIENT SAMPLES HAVE A HIGH MIC FOR THE DRUG VANCOMYCIN FOR THE ISOLATE STAPHYLOCOCCUS AUREUS. ONE ERRONEOUS PATIENT RESULT WAS REPORTED. THERE WAS NO PATIENT TREATMENT CHANGE AS A RESULT. CONFIRMATORY TESTING PERFORMED ON THE MICROSCAN, WHERE THE ISOLATE WAS NOT RESISTANT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1552037 BD PHOENIX¿ PMIC-108 SYSTEM, TEST, AUTOMATED ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION LON BECTON DICKINSON & CO. (SPARKS) 3213323 30382904484188

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown